Mechanisms of Glucose Toxicity
Mechanisms of Glucose Toxicity
批准号:
7762380
负责人:
GERALD Warren HART
金额:
$49.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2012-04-30
关键词:
AffectAmino AcidsBeta CellBiological ModelsBlindnessBloodCardiovascular DiseasesCell physiologyClinical InvestigatorComplications of Diabetes MellitusDataDevelopmentDiabetes MellitusDiabetic NeuropathiesDiabetic RetinopathyDiseaseElectron TransportEnd stage renal failureFatty AcidsGenerationsGenetic TranscriptionGlucoseHexosaminesHyperglycemiaIndividualInsulin ResistanceLeadLearningLinkMedicalMitochondriaModificationMolecularMorbidity - disease rateNeuropathyNutrientOrganismOxidative StressOxygenPathway interactionsPatientsPhosphorylationPhosphotransferasesPlant RootsPost-Translational Protein ProcessingPreventionProtein Kinase CProteinsSP1 geneSamplingScientistSignal TransductionSpecificityStressTissuesToxic effectVirusWestern Worlddiabetic cardiomyopathyhuman diseasemortalitynovelpublic health relevancesensortranscription factor
中文摘要
描述(由申请人提供):糖尿病是导致心血管疾病、终末期肾病、失明和衰弱性神经病变的主要原因。高血糖是这些疾病的根本原因,但葡萄糖毒性的机制尚不清楚。高血糖和氧化应激显著增加了0-linked N-acetylgiucosamine (0-GlcNAc)对蛋白质的酶修饰,这是己糖胺生物合成途径的一个终点。0-GlcNAc是一种动态调控修饰,在所有多细胞生物和感染它们的病毒中,它与蛋白质磷酸化类似,并且与蛋白质磷酸化一样丰富。OGlcNAc和磷酸化之间的动态串扰作为营养/应激传感器来调节信号传导、转录和细胞骨架组装。血液中营养物质的增加,包括氨基酸、脂肪酸和葡萄糖,都会增加细胞蛋白质的葡萄糖酰化。越来越多的证据表明,升高的glcn酰化是胰岛素抵抗和葡萄糖毒性的基础。
英文摘要
DESCRIPTION (provided by applicant): Diabetes is a leading cause of cardiovascular disease, end-stage renal disease, blindness and debilitating neuropathies. Hyperglycemia is the root cause of these maladies, but the mechanisms of glucose toxicity are unclear. Hyperglycemia and oxidative stress dramatically increase the enzymatic modification of proteins by 0-linked N-acetylgiucosamine (0-GlcNAc), an endpoint of the hexosamine biosynthetic pathway. 0-GlcNAc is a dynamic regulatory modification that is both analogous to, and is as abundant as protein phosphorylation in all multi-cellular organisms and viruses that infect them. Dynamic crosstalk between OGlcNAc and phosphorylation serves as a nutrient/stress sensor to regulate signaling, transcription and cytoskeletal assembly. Increased nutrients in the blood, including amino acids, fatty acids and glucose, all increase GlcNAcylation of cellular proteins. Mounting evidence indicates that elevated GlcNAcylation underlies both insulin-resistance and glucose toxicity.
We have assembled a multi-disciplinary team comprised of basic scientists and clinical investigators who are experts in diabetic cardiomyopathy, diabetic retinopathy, diabetic neuropathy and hyperglycemia-induced beta-cell destruction, to elucidate the common fundamental mechanisms underlying glucose toxicity. It is our hypothesis that nutrient-induced hyper-GlcNAcylation is a fundamental mechanism of glucose toxicity, affecting many different cellular processes, including increasing the generation of reactive oxygen by the mitochondria via abnormal GlcNAcylation of electron transport chain components, dysregulation of protein kinase C and other kinases, altering the activity and specificity of transcription factors (eg. SP1), and via affecting functions ofpolyols. By assembling a team of clinicians and biochemists to study glucose toxicity in different model systems that are most relevant to human disease, and in patient samples, we will not only uncover common disease mechanisms, but also will learn how glucose toxicity differentially affects individual tissues. These studies will lead to novel avenues of treatment and prevention of diabetic complications.
PUBLIC HEALTH RELEVANCE: Diabetes is amongst the most prevalent diseases in the Western world. The morbidity and mortality of diabetes is largely due to glucose toxicity. Yet, little is known about the molecular mechanisms as to why excessive glucose is toxic to tissues. We have assembled a team of both medical experts and biochemists to uncover the mechanisms of glucose toxicity in tissues most affected in the disease. The data obtained will allow the development of new preventions and/or treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
-
批准号:10308411
-
项目类别:
-
资助金额:$49.78万
-
财政年份:2020
-
负责人:GERALD Warren HART
-
依托单位:
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
-
批准号:10533317
-
项目类别:
-
资助金额:$49.78万
-
财政年份:2020
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10458006
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10261390
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10668984
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:9329448
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:9754184
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
"Glycosciences Skills Development "
-
批准号:8183699
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Administrative Core
-
批准号:8183684
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8669110
-
项目类别:
-
资助金额:$251.32万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8072358
-
项目类别:
-
资助金额:$243.63万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Crosstalk Between 0-GlcNAcylation and Phosphorylation in Diabetic Cardiomyopathy
-
批准号:8183667
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8289623
-
项目类别:
-
资助金额:$244.69万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:9067492
-
项目类别:
-
资助金额:$225.94万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8477248
-
项目类别:
-
资助金额:$236.62万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Shared Resource Cores
-
批准号:8183701
-
项目类别:
-
资助金额:$62.86万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8853915
-
项目类别:
-
资助金额:$247.05万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8656256
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
O-GlcNAc:Developing New Tool for Assessment of Glycemia
-
批准号:7491662
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2005
-
负责人:GERALD Warren HART
-
依托单位:
O-GlcNAc:Developing New Tool for Assessment of Glycemia
-
批准号:6928686
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2005
-
负责人:GERALD Warren HART
-
依托单位:
海外基金